Trial Profile
Effects of Berberine Hydrochloride and Bifidobacterium in Prediabetes Prevention and Treatment an Open-label, Multicenter-Randomized, Prospective-Controlled Study
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II/III
Latest Information Update: 22 Nov 2018
Price :
$35
*
At a glance
- Drugs Berberine (Primary) ; Bifidobacteria (Primary)
- Indications Prediabetic state
- Focus Therapeutic Use
- 11 Nov 2018 Planned End Date changed from 1 Sep 2016 to 1 Apr 2018.
- 11 Nov 2018 Planned primary completion date changed from 1 Sep 2015 to 1 Apr 2018.
- 11 Nov 2018 Planned initiation date changed from 1 Jun 2014 to 1 Nov 2015.